Part 6: Going Remote During COVID-19: Considerations When Moving Studies Out of the Clinic SettingDownload PDF
In this webinar, our panel of experts discuss what you need to know about the impact of COVID-19 on your clinical trials:
- Informed consent: what’s allowed and what’s practical in obtaining consent remotely, where does electronic consent come in, and whether participant compensation needs to be modified
- How do IRBs consider the review of “virtual” clinical trials?
- What do sponsors consider when deciding whether study visits can be conducted remotely, both when planning ahead, and when reacting to urgent issues?